Myocardial infarction centres: the way forward

H R Andersen1, C J Terkelsen, L Thuesen

  • 1Department of Cardiology B, Skejby University Hospital, DK-8200 Aarhus N, Denmark. henning.rud.andersen@iekf.au.dk

Insights

A prehospital diagnostic strategy is recommended for primary percutaneous coronary intervention (PCI) patients. This approach aims to bypass local hospitals, alert interventional centers, and start medications early, improving treatment times.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Public Health

Background:

  • Primary percutaneous coronary intervention (PCI) is the gold standard for ST-elevation myocardial infarction (STEMI).
  • Current protocols often involve delays by admitting STEMI patients to the nearest hospital, regardless of PCI capability.

Purpose of the Study:

  • To advocate for a shift from local hospital admission to a prehospital diagnostic strategy for STEMI patients.
  • To reduce delays in reperfusion therapy and improve patient outcomes.

Main Methods:

  • This is a conceptual/strategy-based abstract, not detailing specific experimental methods.
  • The proposed strategy involves prehospital diagnosis and direct referral to PCI-capable centers.

Main Results:

  • Direct referral eliminates delays at non-PCI-capable local hospitals.
  • Pre-alerting interventional centers reduces "door-to-balloon" times.
  • Initiation of adjunctive medication in the prehospital phase can be facilitated.

Conclusions:

  • A prehospital diagnostic strategy is essential in the era of primary PCI.
  • Implementing this strategy optimizes patient flow to interventional centers, reduces treatment delays, and improves the efficacy of emergency cardiac care.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...